Drug development in Japan: Opportunities and challenges in drug development

International Journal of Pharmaceutical Medicine

Volumn 21, Issue 5, 2007, Pages 331-338

  Takahashi, Kihito ^a,b,c  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

^b Japan Pharmaceutical Association   (Japan)

^c Japanese Centre of Pharmaceutical Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COST CONTROL; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG RESEARCH; JAPAN; MARKET; POLITICS; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; REVIEW; STANDARD;

EID: 34548661504     PISSN: 13649027     EISSN: 14735679     Source Type: Journal    
DOI: 10.2165/00124363-200721050-00003     Document Type: Review

References (34)

1. Office of Pharmaceutical Industry Research report. 2005 Nov [in Japanese; online]. Available from URL: http://www.jpma.or.jp/opir/single/souyakunoba.pdf [Accessed 2007 Jul 9]
2. Ishibashi K. Office of Pharmaceutical Industry Research news. 2006 Oct 18-21 no. 21 [in Japanese; online]. Available from URL: http://www.jpma.or.jp/ opir/news/news-21.pdf [Accessed 2007 Jul 9]
3. Ebihara A, Takahashi K, Ikemoto F, et al. Clinical pharmacology and clinical trials in Japan. J Mol Med 1996 Aug; 74 (8): 479-86
4. McCurry J. Japan unveils 5-year plan to boost clinical research. Lancet 2007 Apr 21; 369: 1333-6
5. Shimatani K. International competitiveness of the Japanese clinical trials on cost and performance [in Japanese]. Session 1: performance of new drug research and development in Japan and its international competitiveness. In: Takeuchi M, Lagakos SW, editors. Development, evaluation and approval of new drugs-partnership between regulatory agencies, industry and academia. Tokyo: Rinsho Hyoka Kankoukai, 2006: 45-58
6. Varawalla N. Conducting clinical trial in Asia. Appl Clin Trial 2006 Jun 1 [online]. Available from URL: http://www.actmagazine.com/ appliedclinicaltrials/Clinical+Trials/Conducting-Clinical-Trials-in-Asia/ ArticleStandard/Article/detail/334577
7. Gross A, Hirose M. Conducting clinical trials in Asia. Pacific Bridge Medical 2007 Mar [online]. Available from URL: http://www.pacificbridgemedical. com/publications/html/AsiaClinicalTrials2007.htm [Accessed 2007 Jul 9]
8. Policy Speech by Prime Minister Shinzo Abe to the 165th session of the diet. 2006 Sep 29 [online]. Available from URL: ttp://www.kantei.go.jp/foreign/ abespeech/2006/09/29speech_e.html [Accessed 2007 Jul 9]
9. New 5-yearly clinical trial activation plan [in Japanese; online]. Available from URL: http://www.mhlw.go.jp/shingi/2007/03/dl/s0330-5a.pdf [Accessed 2007 Aug 22]
10. A draft of vision for the pharmaceutical industry [in Japanese; online]. Available from URL: http://search.e-gov.go.jp/servlet/Public?CLASSNAME= Pcm1010&BID=495070080&OBJCD=100495&GROUP= [Accessed 2007 Aug 22]
11. Vision to improve the environment for vaccines research, development and production in Japan [in Japanese; online]. Available from URL: http://www.mhlw.go.jp/shingi/2007/03/dl/s0322-13d.pdf [Accessed 2007 Aug 22]
12. Miyajima A. Role of Japan and Asia in countries in global pharmaceutical development. 2006 Symposium of Asia Pacific Economic Conference (APEC) Network. 2006 Oct 12 [online]. Available from URL: http://www.pmda.go.jp/apec2006ph/ presen/1012/03.pdf [Accessed 2007 Jul 9]
13. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-9
14. de Koning Gans HJ. Revolution in Asian drug development: a Korea and Japan experience. In: Experience of a Japan/Korea regional trial. Fourth Kitasato University-Harvard School of Public Health Symposium [online]. Available from URL: http://www.pharm.kitasato-u.ac.jp/biostatis/khsympo2002.html [Accessed 2007 Jul 9]
15. Mori K. Global development: Japanese efforts and views. 2006 Symposium of Asia Pacific Economic Conference (APEC) Network. 2006 Oct 13 [online]. Available from URL: http://www.pmda.go.jp/apec2006ph/presen/1013/12.pdf [Accessed 2007 Jul 9]
16. Key items of 2007 PMDA business plan [in Japanese; online]. Available from URL: http://www.pmda.go.jp/guide/hyougikai/19/h190622gijishidai/file/ h190622 siryo3.pdf [Accessed 2007 Aug 22]
17. The minutes from "2006 PMDA business hyougikai" [in Japanese; online]. Available from URL: http://www.pmda.go.jp/guide/hyougikai/18/ H190306gijishidai/file/h190306gijiroku.pdf [Accessed 2007 Aug 22]
18. Uyama Y. Current status and future perspectives of clinical trial consultation and NDA review performance. Sixth Kitasato University-Harvard School of Public Health Symposium [online]. Available from URL: http://www. pharm.kitasato-u.ac.jp/biostatis/program2005/Khsympo_program 2005.html [Accessed 2007 Jul 9]
19. JPMA News Letter 2007; 119 (5) [in Japanese; online]. Available from URL: http://www.jpma-newsletter.net/PDF/2007_119_02.pdf [Accessed 2007 Aug 22]
20. ICH harmonized tripartite guideline. Ethnic factors in the acceptability of foreign clinical data: E5 (R1) [online]. Available from URL: http://www.ich.org/LOB/media/MEDIA481.pdf [Accessed 2007 Aug 22]
21. ICH harmonized tripartite guideline. Guideline for good clinical practice: E6 (R1) [online]. Available from URL: http://www.ich.org/LOB/media/ MEDIA482.pdf [Accessed 2007 Aug 22]
22. A draft of basic policy on international collaborative clinical trials for public comment [in Japanese; online]. Available from URL: http://www.pmda.go.jp/guide/hyougikai/19/h190608gijishidai/file/shiryo8.pdf [Accessed 2007 Aug 22]
23. E5: ethnic factors in the acceptability of foreign clinical data: questions & answers (R1) [online]. Available from URL: http://www.ich.org/ cache/compo/276-254-1.html [Accessed 2007 Sep 6]
24. Shimatani K. Clinical trial performance and cost survey [in Japanese]. Session 2-1: Japan's critical path opportunities - 1. Reforming the clinical trial process for trial conduct: environment and infrastructure of clinical research and trials. In: Takeuchi M, Lagakos SW, editors. Japan's critical path opportunities. Tokyo: Rinsho Hyoka Kankoukai, 2007: 139-54
25. Umehara S. Field Monitor's scope of work is too broad [in Japanese]. Nikkan Yakugyo 2006 Nov 20
26. Taniguchi T. Improvement in Japan's clinical trial environment: a prospective of global companies: are you ready to use Japanese sites for your global clinical trials? Seventh Kitasato University-Harvard School of Public Health Symposium [in Japanese; online]. Available from URL: http://www.pharm. kitasato-u.ac.jp/ [Accessed 2007 Jul 9]
27. Uchida T, Kobayashi F, Kiko Tanaka K, et al. Promoting clinical trials in Japan. Applied Clinical Trials 2007 Mar 1 [online]. Available from URL: http://www.actmagazine.com/appliedclinicaltrials/Feature+Article/ Promoting-Clinical-Trials-in-Japan/ArticleStandard/Article/detail/410606 [Accessed 2007 Jul 9]
28. Califf RM. Issues facing clinical trial of the future. J Intern Med 2003; 254: 426-33
29. Sekine E. Survey results: current status of EDC use in Japan. Session 2-1. Japan's critical path opportunities - 1. Reforming the clinical trial process for trial conduct: environmental and infrastructure of clinical research and trials. In: Takahashi M, Lagakos SW, editors. Japan's critical path opportunities. Tokyo: Rinsho Hyoka Kankoukai, 131-8
30. Clemens N. Shortfalls of qualified persons in pharmaceutical medicine. IFAPP World I 2007 Apr [online]. Available from URL: http://www.dgpharmed.de/ 01_public/pressemitteilungen/PDFs/IFAPPworld_I_2007.pdf [Accessed 2007 Jul 9]
31. Mayer A. A window of opportunity: the cooperative efforts of government agencies, pharmaceutical manufacturers and academic researchers are helping to modernize Japan's drug development climate. Envisage 2007 Jul; 1 (3): e1 [online]. Available from URL: http://www.envisagemag.com/article.cfm?articleid= 57 [Accessed 2007 Aug 22]
32. Takahashi K. Training of clinical trial specialists and reviewers [in Japanese]. Session 4: Review System and Discussion on Good Review Practice (GRP). In: Takeuchi M, Lagakos SW, editors. Global development strategies of new drugs: achievement and future direction. Tokyo: Rinsho Hyoka Kankoukai, 2005: 295-9
33. Summers K. The pharmaceutical physician. In: Burley DM, Clarke JM, Lasagna L, editors. Pharmaceutical medicine. 2nd ed. London: Edward Arnold, 1993: 290-319
34. Postgraduate courses in pharmaceutical medicine in Europe: a pilot survey. Int J Pharm Med 2001; 15 (6); 293-9 [online]. Available from URL: http://www.uni-due.de/pressestelle/webredaktion/pharmaceutical_medicine/ifapp. pdf [Accessed 2007 Jul 9]